mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
Tetsuo Mashima(Japanese Foundation For Cancer Research), Hiroyuki Seimiya(Japanese Foundation For Cancer Research)
Cited by 30
Related Papers
c-Jun NH2-terminal Kinase-mediated Activation of Interleukin-1β Converting Enzyme/CED-3-like Protease during Anticancer Drug-induced Apoptosis
|Journal of Biological Chemistry|1997|205
Acyl‐CoA synthetase as a cancer survival factor: its inhibition enhances the efficacy of etoposide
|Cancer Science|2009|90
<scp>RK</scp>‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model
|Cancer Science|2018|78
ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer
|Cancer Science|2020|67
Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen Species
|American Journal Of Pathology|2013|56